Warning! Javascript on your browser is not enabled!

We have found that Javascript is disabled on your internet browser. Many features of this site will not work without JavaScript enabled. To get the best possible experience using our website, we recommend that you enable the JavaScript in your browser.

Mission - Partners in Bleeding Disorders Education

Important Announcement!

To reduce risk of COVID-19 exposure among participants and faculty, all Partners Programs will be held as online/virtual programs until further notice. These live/interactive programs will feature similar content delivered by the same speakers as the in-person programs. These virtual programs will also carry continuing education credits for eligible individuals in the target audience(s). Space in the virtual programs is limited, so register today! Please contact Natalie Duncan, nduncan@ihtc.org, with any questions.

Many Experts. One Mission.

The Partners in Bleeding Disorders Education Program promotes excellence in care through education created by and for the federally recognized Hemophilia Treatment Center (HTC) Network and providers from a variety of disciplines that serve patients with bleeding and other coagulation disorders.

Our goal is to provide comprehensive, broad-based education to support the treatment of bleeding and clotting disorders. Programs include the multidisciplinary Basic Partners, Advanced Partners, Presentation Skills Workshop, and PartnersPRN online learning activities. Programs target nurses, social workers, physical therapists, and other members of the HTC multidisciplinary team.

Founded in 1996 by the Indiana Hemophilia and Thrombosis Center (IHTC), oversight of the Partners programs expanded in 2010 to include a nationally representative, multidisciplinary Advisory Board comprising medical professionals as well as representatives from the National Hemophilia Foundation, Hemophilia Foundation of Michigan and the American Thrombosis and Hemostasis Network (ATHN). The Partners in Bleeding Disorders Education Program is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.